Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with prostate cancer of a specific type called adenocarcinoma
- People whose prostate cancer has spread to other parts of the body, is no longer responding to treatments that lower testosterone (castration-resistant), and is getting worse over time
- People whose cancer did not respond well to, or who could not tolerate, certain hormone-blocking drugs (such as abiraterone, enzalutamide, apalutamide, or darolutamide)
- People who have previously received at least one course of a specific type of chemotherapy (taxane-based), OR people who are experiencing symptoms but whose doctor has assessed them as not well enough to have chemotherapy
- People whose general health and ability to carry out daily activities falls within a certain range, rated 0 to 2 on a standard medical scale (meaning anywhere from fully active to capable of some self-care but limited in physical activity) (confirm with trial site)
Who may not be able to join:
- People who do not agree to have their personal data used for clinical research purposes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 04 76 76 54 55
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Confirm prospectively the prognostic value of post-therapy SPECT/CT imaging for response evaluation during [177Lu]Lu- PSMA
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.